Michael Messingham MD in Davenport, Iowa

Home Iowa Davenport

Michael Messingham MD has Dermatology as his primary medical specialty. Their primary office is: 2322 E Kimberly Rd in Davenport, Iowa. They attended Loyola University Of Chicago, Stritch School Of Medicine and graduated in 2000 (around 24 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Michael J Messingham MD Office Phone and Directions

Michael Messingham MD
2322 E Kimberly Rd
Davenport, Iowa 52807
563-355-3376

Patient Ratings
Please rate your experience with Michael Messingham MD below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 563-355-3376

Enter a starting address:

Healthcare Info for Michael Messingham MD

Medical School: Loyola University Of Chicago, Stritch School Of Medicine
Graduation Year: 2000
The Primary Medical Specialty for Michael Messingham MD is listed as: Dermatology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 24
PAC (PECOS ID)#: 4284613290
NPI #: 1558355859
NPI Created On: 09/01/2005
NPI Last Updated Listed as: 11/27/2007
Primary Taxonomy Code: 207NS0135X
License Number:
34780
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Sanford Health Plan
Medicare

They are listed as accepting new patients.

Services and Procedures include:

Drainage of abscess
Tangential biopsy of single skin lesion
Tangential biopsy of additional skin lesion
Removal of malignant growth (1.1 to 2.0 centimeters) of the trunk, arms, or legs
Injection of up to 7 skin growths
Repair of wound (2.6 to 7.5 centimeters) of the scalp, underarms, trunk, arms, and/or legs
Repair of wound (2.6 to 7.5 centimeters) of neck, hands, feet, and/or genitals
Repair of wound (2.6 to 5.0 centimeters) of face, ears, eyelids, nose, lips, and/or mouth
Repair of wound (2.6 to 7.5 centimeters) of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, and/or feet
Destruction of skin growth
Destruction of 2-14 skin growths
Destruction of 15 or more skin growths
Destruction of up to 14 skin growths
Destruction of malignant growth (0.6 to 1.0 centimeters) of trunk, arms, or legs
Destruction of malignant growth (1.1 to 2.0 centimeters) of trunk, arms, or legs
Destruction of malignant growth (1.1 to 2.0 centimeters) of scalp, neck, hands, feet, or genitals
Destruction of malignant growth (0.6 to 1.0 centimeters) of face, ears, eyelids, nose, lips, or mouth
Removal and microscopic examination of growth of the head, neck, hands, feet, or genitals (first stage, up to 5 tissue blocks)
Removal and microscopic examination of growth of the head, neck, hands, feet, or genitals
Removal and microscopic examination of growth of the trunk, arms, or legs (first stage, up to 5 tissue blocks)

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $27

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 826393071

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Inflammation

Name of Drug #1: Otezla

Open Associated Drug #1: 55513-137-60